Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union.

Mohammed A AlnuhaitAbdullah AlshammariManar AlharbiLina AlOtaibiReem AlharbiAttiah KhobraniNora AlkhudairMajed AlshamraniAbdullah M Alrajhi

Published in: Therapeutic innovation & regulatory science (2024)

This study highlights the significance of mitigating drug lag to enhance global healthcare outcomes and patient access to innovative therapies. Further research and collaborative efforts are essential to bridging these disparities and promoting equitable healthcare worldwide.

Keyphrases

healthcare
saudi arabia
quality improvement
palliative care
case report
adverse drug
emergency department
affordable care act
metabolic syndrome
health information
social media
adipose tissue